Egyptian International Pharmaceutical Industries 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Ahmed Saeed Killani

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

CEO

Ahmed Saeed Killani

no data

테뉴어

Dr. Ahmed Saeed Mohamed Killani serves as the Chairman of the Board and Managing Director at Egyptian International Pharmaceutical Industries Company.

Egyptian International Pharmaceutical Industries 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

No independent directors

No independent directors

Recent updates

Third quarter 2024 earnings released

Price target increased by 15% to ج.م69.46

Second quarter 2024 earnings released

Now 21% undervalued

Egyptian International Pharmaceutical Industries Company(CASE:PHAR) dropped from EGX 30 Index

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of ج.م2.00 per share

Dividend of ج.م2.00 announced

Now 21% overvalued after recent price rise

Now 21% overvalued after recent price rise

Price target increased by 19% to ج.م72.20

New minor risk - Shareholder dilution

Investor sentiment improves as stock rises 20%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

Full year 2022 earnings released

Investor sentiment deteriorates as stock falls 15%

Price target decreased to ج.م63.87

No independent directors

Second quarter 2022 earnings released

No independent directors

Third quarter 2021 earnings released

Second quarter 2021 earnings released

Inaugural dividend of ج.م2.95 per share

Price target decreased to ج.م64.07

New 90-day low: ج.م42.53

Earnings beat expectations, revenue disappoints

New 90-day high: ج.م48.51

New 90-day low: ج.م45.00

New 90-day low - ج.م46.61

CEO

테뉴어